✦ LIBER ✦

Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A

✍ Scribed by M. E. MANCUSO; P. M. MANNUCCI; A. ROCINO; I. GARAGIOLA; A. TAGLIAFERRI; E. SANTAGOSTINO

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensive Exposure to Factor VIII May Be

✍ Carcao Manuel D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Eradication of factor viii inhibitors in

✍ Christine L. Kempton; Geoff Allen; Jeffrey Hord; Rebecca Kruse-Jarres; Rajiv K. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Cardiac tamponade in a patient with mode

✍ Nina Ghosh; Patrick Teefy; Lori Laudenbach; Georges-Etienne Rivard 📂 Article 📅 2006 🏛 Pulsus Group Inc 🌐 English ⚖ 237 KB

Purity of factor VIII product and incide

✍ E. P. Mauser-Bunschoten; J. G. Van Der Bom; M. Bongers; M. Twijnstra; G. Ro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Incidence of inhibitors in patients with

✍ Dr. Iise Schwarzinger; Ingrid Pabinger; Christian Korninger; Ferdinand Haschke; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 2 views

Case of acquired hemophilia with factor

✍ Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Eiji Koike; Mitsuhiro Tsuritan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB